Össur hf. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 24, 2023 at 02:00 am EDT
Share
Össur hf. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 192.92 million compared to USD 176.7 million a year ago. Net income was USD 13.89 million compared to USD 6.76 million a year ago. Basic earnings per share from continuing operations was USD 0.033 compared to USD 0.016 a year ago. Diluted earnings per share from continuing operations was USD 0.033 compared to USD 0.016 a year ago.
For the nine months, sales was USD 575.49 million compared to USD 527.71 million a year ago. Net income was USD 39.4 million compared to USD 29.61 million a year ago. Basic earnings per share from continuing operations was USD 0.095 compared to USD 0.073 a year ago. Diluted earnings per share from continuing operations was USD 0.095 compared to USD 0.073 a year ago.
Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.